✦ LIBER ✦

123I-BZA2 as a Melanin-Targeted Radiotracer for the Identification of Melanoma Metastases: Results and Perspectives of a Multicenter Phase III Clinical Trial

✍ Scribed by Cachin, F.; Miot-Noirault, E.; Gillet, B.; Isnardi, V.; Labeille, B.; Payoux, P.; Meyer, N.; Cammilleri, S.; Gaudy, C.; Razzouk-Cadet, M.; Lacour, J. P.; Granel-Brocard, F.; Tychyj, C.; Benbouzid, F.; Grange, J. D.; Baulieu, F.; Kelly, A.; Merlin, C.; Mestas, D.; Gachon, F.; Chezal, J. M.; Degoul, F.; D'Incan, M.

Book ID: 127091400
Publisher: The Society of Nuclear Medicine
Year: 2013
Tongue: English
Weight: 802 KB
Volume: 55
Category: Article
ISSN: 0161-5505
DOI: 10.2967/jnumed.113.123554

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and Doxorubicin Compared With

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

✍ Nabholtz, J.-M. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 150 KB

First results of a randomized phase III

First results of a randomized phase III trial comparing exemestane versus tamoxifen as first-line hormone therapy (HT) for postmenopausal women with metastatic breast cancer (MBC) — EORTC 10951 in collaboration with the exemestane working group and NCIC Clinical Trials Group

✍ R Paridaens; P Therasse; L Dirix; L Beex; M.J Piccart; D Cameron; T Cufer; K Roo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB